Company: University of Texas MD Anderson Cancer Center
Job title: MD, Professor, Hematopathology
Dr. Routbort is a practicing molecular pathologist and bioinformatician at the University of Texas MD Anderson Cancer Center, where he develops and supports the computational pipelines and reporting tools for next generation sequencing in the clinical Molecular Diagnostics Laboratory.
Receiving a Master’s degree in Biochemistry and Molecular Biology from the University of Chicago, and later his MD and PhD degrees at Duke University, he joined the faculty at MD Anderson in 2004, where he has focused his informatics efforts on initiatives directed at improving pathologist and lab workflow, and on improving the generation, storage, reporting, and retrieval of pathology and laboratory data. He currently serves as Director of Computational and Integrational Pathology for the Division of Pathology and Laboratory Medicine, facilitating the transactional and integrational use of genomic data both internally and with large scale multi-institutional collaborations like NCI-MATCH and AACR Project GENIE.
Session Q+A 11:00 am
Bringing together the perspectives of the session’s expert speakers, this is your chance to challenge viewpoints, ask any pending questions or bring new discussion points key to advancing clinical trial design, execution and clinical utility demonstration. • How can we maximize patient enrolment in large clinical trials? • Exploring strategies to navigate the analysis of…Read more
day: Day Two
Liquid Biopsy in the Clinic: Lessons from Use in Clinical Care & Clinical Trials 10:30 am
• Become familiar with the ‘compartment of origin’ challenge for liquid biopsy interpretation • Compare sensitivity and positive predictive value considerations for liquid biopsy • Review established and emerging genomic mechanisms of resistance for targeted therapy for solid tumors and the ability of liquid biopsy to detect themRead more
day: Day Two